NanoenTek
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
NanoenTek makes life-science and medical diagnostic instruments, the kind of devices used to analyze biological samples in laboratory and clinical settings.
Its products reach customers through its own US marketing subsidiary, NanoEnTek America Inc., which handles regional sales in the American market, while a related entity, AAI Healthcare, provides personalized healthcare services to business clients in South Korea. The company is listed on KOSDAQ, South Korea's technology and small-cap exchange.
Summary is AI-generated and may contain errors · figures from DART filings
The company's largest shareholder has changed hands multiple times in recent years, most recently shifting to Eplus Asset Advisor following a series of share transfers and capital increases.
NanoenTek in five facts
What does NanoenTek do?
NanoenTek makes life-science and medical diagnostic instruments, the kind of devices used to analyze biological samples in laboratory and clinical settings.
Where is NanoenTek listed and in which sector?
NanoenTek (Korean name: 나노엔텍) trades under KRX code 039860 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is NanoenTek?
Its market capitalisation was US$132M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were NanoenTek's latest annual revenue and operating profit?
For fiscal year 2025, NanoenTek reported revenue of US$28.8M, operating profit of US$831.4K and net income of US$1.2M, per its annual report on DART (data retrieved from DART on 2026-09-08). Revenue was up 25.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-08
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Material event report (treasury share trust agreement)Sep 1
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
NanoenTek reported consolidated results for FY2025: revenue of US$25.4M (+25.1% year on year), operating profit of US$733K (+77.4% year on year) and net income of US$1.05M (−55.9% year on year).
Earnings · Mar 16